Gradient reduction after percutaneous septal ablation modifies the risk profile in hypertrophic obstructive cardiomyopathy

被引：0
|
作者：
Faber, L. [1 ]
Burghardt, A. [1 ]
Seggewiss, H. [2 ]
Van Buuren, F. [1 ]
Horstkotte, D. [1 ]
机构：
[1] Ruhr Univ Bochum, Heart & Diabet Ctr North Rhine Westphalia, Dept Cardiol, Bad Oeynhausen, Germany
[2] Leopoldina Hosp, Med Clin 1, Schweinfurt, Germany
来源：
EUROPEAN HEART JOURNAL | 2015年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P2638
引用
收藏
页码：452 / 453
页数：2
相关论文
共 50 条
  • [1] Percutaneous septal ablation in hypertrophic obstructive cardiomyopathy
    Faber, Lothar
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2006, 11 (10) : 423 - 431
  • [2] Prediction of the risk of pacemaker dependency after percutaneous septal ablation for hypertrophic obstructive cardiomyopathy
    Faber, L
    Seggewiss, H
    Werlemann, BC
    Fassbender, D
    Schmidt, HK
    Horstkotte, D
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 173A - 173A
  • [3] Percutaneous septal ablation after previous myectomy in hypertrophic obstructive cardiomyopathy
    Faber, L.
    Welge, D.
    Seggewiss, H.
    Koerfer, R.
    Kleikamp, G.
    Horstkotte, D.
    EUROPEAN HEART JOURNAL, 2006, 27 : 236 - 236
  • [4] Role of percutaneous septal ablation in hypertrophic obstructive cardiomyopathy
    Kimmelstiel, CD
    Maron, BJ
    CIRCULATION, 2004, 109 (04) : 452 - 456
  • [5] Percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy
    Seggewiss, H
    Faber, L
    Gleichmann, U
    THORACIC AND CARDIOVASCULAR SURGEON, 1999, 47 (02): : 94 - 100
  • [6] Predicting the risk of atrioventricular conduction lesions after percutaneous septal ablation for obstructive hypertrophic cardiomyopathy
    Faber, L
    Seggewiss, H
    Welge, D
    Fassbender, D
    Ziemssen, P
    Schmidt, HK
    Gleichmann, U
    Horstkotte, D
    ZEITSCHRIFT FUR KARDIOLOGIE, 2003, 92 (01): : 39 - 47
  • [7] Percutaneous septal ablation for hypertrophic obstructive cardiomyopathy: How much CK is necessary for significant reduction of the outflow gradient?
    Welge, D
    Fassbender, D
    Schmidt, HK
    Horstkotte, D
    Faber, L
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 179A - 179A
  • [8] Telecardiology in the monitoring after percutaneous alcohol septal ablation of obstructive hypertrophic cardiomyopathy
    Moltrasio, M
    Cozzi, S
    Berna, G
    Galli, S
    Doria, E
    Polvani, GL
    Famoso, G
    Borghini, E
    Fassini, G
    Bartorelli, AL
    HEART DISEASE: NEW TRENDS IN RESEARCH, DIAGNOSIS AND TREATMENT, 2001, : 479 - 482
  • [9] Percutaneous Transluminal Septal Myocardial Ablation in Hypertrophic Obstructive Cardiomyopathy
    Yuan, J. S.
    Qiao, S. B.
    You, S. J.
    Gao, R. L.
    Duan, F. J.
    Tian, Y. Q.
    Yang, W. X.
    Hu, F. H.
    Chen, J. L.
    CARDIOLOGY, 2009, 114 : 120 - 121
  • [10] Percutaneous Intramyocardial Septal Radiofrequency Ablation for Hypertrophic Obstructive Cardiomyopathy
    Liu, Liwen
    Li, Jing
    Zuo, Lei
    Zhang, Jinzhou
    Zhou, Mengyao
    Xu, Bo
    Hahn, Rebeccca T.
    Leon, Martin B.
    Hsi, David H.
    Ge, Junbo
    Zhou, Xiaodong
    Zhang, Jun
    Ge, Shuping
    Xiong, Lize
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (16) : 1898 - 1909
12345